These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 7973520

  • 1. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J.
    Schweiz Med Wochenschr; 1994 Nov 05; 124(44):1933-7. PubMed ID: 7973520
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec 05; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 3. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995 Dec 05; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.
    Metabolism; 2003 Jan 05; 52(1):116-21. PubMed ID: 12524671
    [Abstract] [Full Text] [Related]

  • 5. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA.
    Acta Endocrinol Suppl (Copenh); 1985 Jan 05; 272():27-30. PubMed ID: 3869424
    [Abstract] [Full Text] [Related]

  • 6. The contribution of lipids to coronary heart disease in diabetes mellitus.
    Stewart MW, Laker MF, Alberti KG.
    J Intern Med Suppl; 1994 Jan 05; 736():41-6. PubMed ID: 7986307
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA.
    Arterioscler Thromb Vasc Biol; 2004 Dec 05; 24(12):2397-402. PubMed ID: 15458975
    [Abstract] [Full Text] [Related]

  • 8. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M.
    Metabolism; 2006 Jul 05; 55(7):879-84. PubMed ID: 16784958
    [Abstract] [Full Text] [Related]

  • 9. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P.
    Klin Wochenschr; 1990 Jul 05; 68 Suppl 22():54-8. PubMed ID: 2087080
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis of dyslipidemia in type 2 diabetes.
    Taskinen MR.
    Exp Clin Endocrinol Diabetes; 2001 Jul 05; 109 Suppl 2():S180-8. PubMed ID: 11460569
    [Abstract] [Full Text] [Related]

  • 11. Diabetic dyslipidaemia.
    Erkelens DW.
    Eur Heart J; 1998 Jul 05; 19 Suppl H():H27-40. PubMed ID: 9717062
    [Abstract] [Full Text] [Related]

  • 12. Dyslipoproteinaemia in manifest diabetes.
    Manzato E, Crepaldi G.
    J Intern Med Suppl; 1994 Jul 05; 736():27-31. PubMed ID: 7986305
    [Abstract] [Full Text] [Related]

  • 13. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J, James RW, Makoundou V, Bioletto S, Golay A.
    Diabetes Metab; 2001 Dec 05; 27(6):701-8. PubMed ID: 11852380
    [Abstract] [Full Text] [Related]

  • 14. An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic -- relevance to high-carbohydrate diets.
    McCarty MF.
    Med Hypotheses; 2004 Dec 05; 63(6):1065-73. PubMed ID: 15504577
    [Abstract] [Full Text] [Related]

  • 15. Lipid modification in type 2 diabetes: the role of LDL and HDL.
    Vergès B.
    Fundam Clin Pharmacol; 2009 Dec 05; 23(6):681-5. PubMed ID: 19650852
    [Abstract] [Full Text] [Related]

  • 16. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS, Aslam M, Naveed AK, Razi MS.
    Saudi Med J; 2006 Feb 05; 27(2):174-80. PubMed ID: 16501671
    [Abstract] [Full Text] [Related]

  • 17. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T, Hanefeld M.
    Exp Clin Endocrinol Diabetes; 2004 Feb 05; 112(2):75-9. PubMed ID: 15031770
    [Abstract] [Full Text] [Related]

  • 18. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov 05; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 19. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D, Krone W.
    Herz; 1995 Feb 05; 20(1):33-46. PubMed ID: 7713475
    [Abstract] [Full Text] [Related]

  • 20. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
    May HT, Anderson JL, Pearson RR, Jensen JR, Horne BD, Lavasani F, Yannicelli HD, Muhlestein JB.
    Am J Cardiol; 2008 Feb 15; 101(4):486-9. PubMed ID: 18312763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.